Protein Sequencing Market Size, Share & Trends Growth [2031]

Protein Sequencing Market Size, Share & Trends Growth [2031]

Segments - Protein Sequencing Market By Products and Services (Instruments, Reagents & Consumables, and Software & Service), Technology (Sequencing-by-degradation, Sequencing-by-transit, and Sequencing-by-affinity), Application (Biomarker Discovery, Protein Engineering Studies, Biotherapeutics, and Others), End-user (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-6154 | 4.9 Rating | 67 Reviews | 321 Pages | Format : PDF Excel PPT

Report Description


Protein Sequencing Market Outlook

The Global Protein Sequencing Market was estimated at USD 1,143.0 Mn in 2022 and is anticipated to reach USD ~1,656.4 Mn by 2031, expanding at a CAGR of 4.4% during the forecast period. 

Protein sequencing: Protein sequencing refers to the process of determining the amino acid sequence of all or part of a protein or peptide. It serves to identify the protein or characterize its post-translational modifications. Typically, partial sequencing of a protein provides sufficient information (one or more sequence tags) to identify it with reference to databases of protein sequences derived from the conceptual translation of genes.

Protein Sequencing Market Outlook

Macro-economic Factors

Government Policies

Governments, including ministries of health and other related ministries and agencies, play a crucial role in the overall development of a strong healthcare system in a region. Stringent policies of government determine the growth and decline of a specific market in a particular country. These government policies differ from country to country or region to region.

In North America, the protein sequencing market is regulated by several government bodies, such as the US Food and Drug Administration (FDA) and Health Canada. They have enforced strict regulations to ensure the high quality and safety of protein sequencing technologies. Regulations cover various aspects, such as device functionality, effectiveness, labeling, production process, and post-market surveillance.

Protein Sequencing Market Dynamics

Market Driver- Rising Prevalence of Chronic Diseases Requiring Protein Sequencing

The global protein sequencing market is registering significant growth, due to the rising prevalence of chronic diseases, such as cancer, Alzheimer's, and Parkinson's. Protein sequencing is a crucial technique that is used to determine the amino acid sequence of proteins, which is essential for understanding their structure, function, and interaction with other molecules.

Increasing incidence of chronic diseases has led to a surge in demand for protein sequencing, as it helps in the identification of disease-causing mutations, development of targeted therapies, and personalized medicine.


Cancer is a leading cause of death worldwide, with an estimated 18.1 million new cancer cases and 9.6 million cancer-related deaths in 2020, according to the World Health Organization (WHO). Protein sequencing is used to identify genetic mutations that drive cancer growth and progression, as well as to develop targeted therapies that selectively kill cancer cells while sparing healthy cells.

Market Restraint- High Cost of Protein Sequencing Equipment and Procedures

High cost of protein sequencing equipment and procedures is restraining the protein sequencing market. The cost of mass spectrometry instruments, which are the primary tools used for protein sequencing, ranges from several hundred thousand to millions of dollars. This high cost makes it difficult for small research institutions and laboratories to invest in these technologies, limiting their access to the latest protein sequencing techniques.

Several companies are developing technologies that offer low costs and high throughput to address the high cost of protein sequencing equipment and procedures. For example, Thermo Fisher Scientific has developed its Orbitrap Fusion Lumos mass spectrometer, which offers higher sensitivity and resolution than traditional mass spectrometry instruments at a lower cost.

Similarly, Bruker Corporation has developed timsTOF Pro 96 mass spectrometer, which offers higher sensitivity and resolution than traditional mass spectrometry instruments at a lower cost per sample.

Market Opportunity- Expanding Pharmaceutical and Biotechnology Industry Globally

The expansion of the pharmaceutical and biotechnology industry globally is driving the market by several factors. Protein sequencing is a critical step in the development of drugs, diagnostics, and therapeutics, as it provides detailed information about the structure and function of proteins, which are essential for understanding their role in various biological processes.

One of the major factors driving the expansion of protein sequencing in the pharmaceutical and biotechnology industry is the increasing demand for personalized medicine. Protein sequencing allows for the identification of genetic variations that affect protein function, which is crucial for developing targeted therapies that are tailored to an individual's genetic makeup.

For instance, Thermo Fisher Scientific has been investing in R&D activities to develop mass spectrometry-based solutions for proteomics research, such as its Orbitrap Fusion Lumos mass spectrometer, which offers high sensitivity and resolution for protein identification and quantification. Similarly, Bruker Corporation has been developing technologies, such as its timsTOF Pro 96 mass spectrometer, which offers high sensitivity and resolution for protein sequencing applications.

Scope of Protein Sequencing Market Report            

The report on the global Protein Sequencing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Protein Sequencing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023–2031

Segmentation

By Products and Services (Instruments, Reagents & Consumables, and Software & Service), By Technology (Sequencing-by-degradation, Sequencing-by-transit, and Sequencing-by-affinity), By Application (Biomarker Discovery, Protein Engineering Studies, Biotherapeutics, and Others), By End-user (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others)

Regional Scope

Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

Charles River Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation,  Selvita SA, SGS SA, Bruker, Rapid Novor Inc, Bioinformatics Solutions, Proteome Factory, AltaBioscience Ltd, Creative Proteomics, and Quantum-Si, Inc.


Protein Sequencing Market Segmental Outlook

Based on Products and Services, the market is segmented into instruments, reagents & consumables, and software & services. The instruments segment is expected to hold a considerable share of the market during the forecast, as instruments are widely used to characterize post-translational modifications.

Protein post-translational modifications (PTMs) increase the functional diversity of the proteome by the covalent addition of functional groups or proteins, proteolytic cleavage of regulatory subunits, or degradation of entire proteins.

Protein Sequencing Market Product and Service

On the basis of Technology, the market is fragmented into sequencing-by-degradation, sequencing-by-transit, and sequencing-by-affinity. The sequencing-by-degradation held the significant share of the market in 2022. It is a well-known method for obtaining amino acid (AA) sequences from a peptide by sequential reactions that release the N-terminal AAs from the peptide as a phenylthiohydantoin (PTH) derivative.

Protein Sequencing Market Technology

In terms of Application, the market is classified as biomarker discovery, protein engineering studies, biotherapeutics, and others. The biomarker discovery segment is anticipated to expand at a significant CAGR during the forecast period, as proteomics biomarker discovery is crucial in a variety of diseases, such as cancer, cardiovascular diseases, acquired immune deficiency syndrome (AIDS), renal diseases, and diabetes.

On the basis of End-user, the market is fragmented into academic institutes & research centers, pharmaceutical & biotechnology companies, contract research organizations, and others. The pharmaceutical & biotechnology companies held the significant share of the market in 2022, as these companies widely use protein sequencing in various ways, including drug discovery, target identification, and the development of personalized medicine.

Regional Outlook

Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022. The protein sequencing market in North America is influenced by several factors. The growth of the market in the region is attributed to the presence of well-established academic institutions and research centers in the region and increasing funding in R&D.

For instance, according to the National Center for Science and Engineering Statistics (NCSES), total research & experimental development (R&D)​ performed in the US totaled USD 717.0 billion in 2020.

Protein Sequencing Market Region

   Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Protein Sequencing Market

  • Historical, Current, and Projected Market Size in Terms of Value

  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

  • Industry Drivers, Restraints, and Opportunities Covered in the Study

  • Recent Industry Trends and Developments

  • Competitive Landscape & Strategies of Key Players

Segments

By Products and Services

  • Instruments
  • Reagents & Consumables
  • Software & Service

By Technology

  • Sequencing-by-degradation
  • Sequencing-by-transit
  • Sequencing-by-affinity

By Application

  • Biomarker Discovery
  • Protein Engineering Studies
  • Biotherapeutics
  • Others

By End-user

  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • Charles River Laboratories
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Selvita SA
  • SGS SA
  • Bruker
  • Rapid Novor Inc
  • Bioinformatics Solutions
  • Proteome Factory
  • AltaBioscience Ltd
  • Creative Proteomics
  • Quantum-Si, Inc.

Competitive Landscape

Manufacturers operating in the global Protein Sequencing market are Charles River Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, Selvita SA, SGS SA, Bruker, Rapid Novor Inc, Bioinformatics Solutions, Proteome Factory, AltaBioscience Ltd, Creative Proteomics, and Quantum-Si, Inc.

Market players are pursuing strategies such as acquisitions, product launches, collaborations, and geographic expansion to leverage untapped opportunities in the global Protein Sequencing market.   

Key Developments:

  • In 2023, Thermo Fisher Scientific Inc. and Olink Holding AB, a key provider of next-generation proteomics solutions, announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash.

  • In 2023, Agilent Technologies, Inc. announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass spectrometers that enables biological researchers to develop biotherapeutic products quickly to treat disease.

Protein Sequencing Market Key Players

Frequently Asked Questions

Rising Prevalence of Chronic Diseases Requiring Protein Sequencing is the factors expected to drive the market growth during the forecast period.

According to this Growth Market Reports report, the global Protein Sequencing market is likely to register a CAGR of 4.4% during the forecast period 2023-2031, with a projected valuation of USD ~ 1,656.4 million by the end of 2031.

Factors such as Government Policies is analyzed in the final report.

Major manufacturers include Charles River Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, Selvita SA, SGS SA, Bruker, Rapid Novor Inc, Bioinformatics Solutions, Proteome Factory, AltaBioscience Ltd, Creative Proteomics, and Quantum-Si, Inc.

The pandemic had a significant impact on various markets, including the Protein Sequencing market. Throughout the COVID-19 pandemic, SARS-CoV-2 has mutated in ways that have significantly impacted pathogenesis. Epidemiological studies significantly show different risks of severe diseases, owing to various COVID-19 variants such as Delta & Omicron, although primarily lack resolution at the level of specific combinations of changes in viral genome sequences.

In addition to market size (in US$ Million), Current & Future Market Trends, Landscape of single-molecule protein sequencing technologies, is provided in the final report.

The forecast year considered for the global Protein Sequencing market report is 2031.

The base year considered for the global Protein Sequencing market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Protein Sequencing Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Protein Sequencing Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Protein Sequencing Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Protein Sequencing Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Protein Sequencing Market Size & Forecast, 2016-2031
      4.5.1 Protein Sequencing Market Size and Y-o-Y Growth
      4.5.2 Protein Sequencing Market Absolute $ Opportunity
   4.6 Current & Future Market Trends
   4.7 Landscape of single-molecule protein sequencing technologies
   4.8 Nanopore Sequencing Technology: Overview
   4.9 Post Translational Modifications (PTMs): Overview
   4.10 Epigenetic Modifications: Overview
   4.11 Sample Preparations and Protein Analysis: Overview
Chapter 5 Global Protein Sequencing Market Analysis and Forecast By Products and Services
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Products and Services
      5.1.2 Basis Point Share (BPS) Analysis By Products and Services
      5.1.3 Absolute $ Opportunity Assessment By Products and Services
   5.2 Protein Sequencing Market Size Forecast By Products and Services
      5.2.1 Instruments
      5.2.2 Reagents & Consumables
      5.2.3 Software & Services
   5.3 Market Attractiveness Analysis By Products and Services
Chapter 6 Global Protein Sequencing Market Analysis and Forecast By Technology
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Technology
      6.1.2 Basis Point Share (BPS) Analysis By Technology
      6.1.3 Absolute $ Opportunity Assessment By Technology
   6.2 Protein Sequencing Market Size Forecast By Technology
      6.2.1 Sequencing-by-degradation
      6.2.2 Sequencing-by-transit
      6.2.3 Sequencing-by-affinity
   6.3 Market Attractiveness Analysis By Technology
Chapter 7 Global Protein Sequencing Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Protein Sequencing Market Size Forecast By Application
      7.2.1 Biomarker Discovery
      7.2.2 Protein Engineering Studies
      7.2.3 Biotherapeutics
      7.2.4 Others
   7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Protein Sequencing Market Analysis and Forecast By End-User
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-User
      8.1.2 Basis Point Share (BPS) Analysis By End-User
      8.1.3 Absolute $ Opportunity Assessment By End-User
   8.2 Protein Sequencing Market Size Forecast By End-User
      8.2.1 Academic Institutes & Research Centers
      8.2.2 Pharmaceutical & Biotechnology Companies
      8.2.3 Contract Research Organizations
      8.2.4 Others
   8.3 Market Attractiveness Analysis By End-User
Chapter 9 Global Protein Sequencing Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Protein Sequencing Market Size Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Protein Sequencing Analysis and Forecast
   11.1 Introduction
   11.2 North America Protein Sequencing Market Size Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Protein Sequencing Market Size Forecast By Products and Services
      11.6.1 Instruments
      11.6.2 Reagents & Consumables
      11.6.3 Software & Services
   11.7 Basis Point Share (BPS) Analysis By Products and Services
   11.8 Absolute $ Opportunity Assessment By Products and Services
   11.9 Market Attractiveness Analysis By Products and Services
   11.10 North America Protein Sequencing Market Size Forecast By Technology
      11.10.1 Sequencing-by-degradation
      11.10.2 Sequencing-by-transit
      11.10.3 Sequencing-by-affinity
   11.11 Basis Point Share (BPS) Analysis By Technology
   11.12 Absolute $ Opportunity Assessment By Technology
   11.13 Market Attractiveness Analysis By Technology
   11.14 North America Protein Sequencing Market Size Forecast By Application
      11.14.1 Biomarker Discovery
      11.14.2 Protein Engineering Studies
      11.14.3 Biotherapeutics
      11.14.4 Others
   11.15 Basis Point Share (BPS) Analysis By Application
   11.16 Absolute $ Opportunity Assessment By Application
   11.17 Market Attractiveness Analysis By Application
   11.18 North America Protein Sequencing Market Size Forecast By End-User
      11.18.1 Academic Institutes & Research Centers
      11.18.2 Pharmaceutical & Biotechnology Companies
      11.18.3 Contract Research Organizations
      11.18.4 Others
   11.19 Basis Point Share (BPS) Analysis By End-User
   11.20 Absolute $ Opportunity Assessment By End-User
   11.21 Market Attractiveness Analysis By End-User
Chapter 12 Europe Protein Sequencing Analysis and Forecast
   12.1 Introduction
   12.2 Europe Protein Sequencing Market Size Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Protein Sequencing Market Size Forecast By Products and Services
      12.6.1 Instruments
      12.6.2 Reagents & Consumables
      12.6.3 Software & Services
   12.7 Basis Point Share (BPS) Analysis By Products and Services
   12.8 Absolute $ Opportunity Assessment By Products and Services
   12.9 Market Attractiveness Analysis By Products and Services
   12.10 Europe Protein Sequencing Market Size Forecast By Technology
      12.10.1 Sequencing-by-degradation
      12.10.2 Sequencing-by-transit
      12.10.3 Sequencing-by-affinity
   12.11 Basis Point Share (BPS) Analysis By Technology
   12.12 Absolute $ Opportunity Assessment By Technology
   12.13 Market Attractiveness Analysis By Technology
   12.14 Europe Protein Sequencing Market Size Forecast By Application
      12.14.1 Biomarker Discovery
      12.14.2 Protein Engineering Studies
      12.14.3 Biotherapeutics
      12.14.4 Others
   12.15 Basis Point Share (BPS) Analysis By Application
   12.16 Absolute $ Opportunity Assessment By Application
   12.17 Market Attractiveness Analysis By Application
   12.18 Europe Protein Sequencing Market Size Forecast By End-User
      12.18.1 Academic Institutes & Research Centers
      12.18.2 Pharmaceutical & Biotechnology Companies
      12.18.3 Contract Research Organizations
      12.18.4 Others
   12.19 Basis Point Share (BPS) Analysis By End-User
   12.20 Absolute $ Opportunity Assessment By End-User
   12.21 Market Attractiveness Analysis By End-User
Chapter 13 Asia Pacific Protein Sequencing Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Protein Sequencing Market Size Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Protein Sequencing Market Size Forecast By Products and Services
      13.6.1 Instruments
      13.6.2 Reagents & Consumables
      13.6.3 Software & Services
   13.7 Basis Point Share (BPS) Analysis By Products and Services
   13.8 Absolute $ Opportunity Assessment By Products and Services
   13.9 Market Attractiveness Analysis By Products and Services
   13.10 Asia Pacific Protein Sequencing Market Size Forecast By Technology
      13.10.1 Sequencing-by-degradation
      13.10.2 Sequencing-by-transit
      13.10.3 Sequencing-by-affinity
   13.11 Basis Point Share (BPS) Analysis By Technology
   13.12 Absolute $ Opportunity Assessment By Technology
   13.13 Market Attractiveness Analysis By Technology
   13.14 Asia Pacific Protein Sequencing Market Size Forecast By Application
      13.14.1 Biomarker Discovery
      13.14.2 Protein Engineering Studies
      13.14.3 Biotherapeutics
      13.14.4 Others
   13.15 Basis Point Share (BPS) Analysis By Application
   13.16 Absolute $ Opportunity Assessment By Application
   13.17 Market Attractiveness Analysis By Application
   13.18 Asia Pacific Protein Sequencing Market Size Forecast By End-User
      13.18.1 Academic Institutes & Research Centers
      13.18.2 Pharmaceutical & Biotechnology Companies
      13.18.3 Contract Research Organizations
      13.18.4 Others
   13.19 Basis Point Share (BPS) Analysis By End-User
   13.20 Absolute $ Opportunity Assessment By End-User
   13.21 Market Attractiveness Analysis By End-User
Chapter 14 Latin America Protein Sequencing Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Protein Sequencing Market Size Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Protein Sequencing Market Size Forecast By Products and Services
      14.6.1 Instruments
      14.6.2 Reagents & Consumables
      14.6.3 Software & Services
   14.7 Basis Point Share (BPS) Analysis By Products and Services
   14.8 Absolute $ Opportunity Assessment By Products and Services
   14.9 Market Attractiveness Analysis By Products and Services
   14.10 Latin America Protein Sequencing Market Size Forecast By Technology
      14.10.1 Sequencing-by-degradation
      14.10.2 Sequencing-by-transit
      14.10.3 Sequencing-by-affinity
   14.11 Basis Point Share (BPS) Analysis By Technology
   14.12 Absolute $ Opportunity Assessment By Technology
   14.13 Market Attractiveness Analysis By Technology
   14.14 Latin America Protein Sequencing Market Size Forecast By Application
      14.14.1 Biomarker Discovery
      14.14.2 Protein Engineering Studies
      14.14.3 Biotherapeutics
      14.14.4 Others
   14.15 Basis Point Share (BPS) Analysis By Application
   14.16 Absolute $ Opportunity Assessment By Application
   14.17 Market Attractiveness Analysis By Application
   14.18 Latin America Protein Sequencing Market Size Forecast By End-User
      14.18.1 Academic Institutes & Research Centers
      14.18.2 Pharmaceutical & Biotechnology Companies
      14.18.3 Contract Research Organizations
      14.18.4 Others
   14.19 Basis Point Share (BPS) Analysis By End-User
   14.20 Absolute $ Opportunity Assessment By End-User
   14.21 Market Attractiveness Analysis By End-User
Chapter 15 Middle East & Africa (MEA) Protein Sequencing Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Protein Sequencing Market Size Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Protein Sequencing Market Size Forecast By Products and Services
      15.6.1 Instruments
      15.6.2 Reagents & Consumables
      15.6.3 Software & Services
   15.7 Basis Point Share (BPS) Analysis By Products and Services
   15.8 Absolute $ Opportunity Assessment By Products and Services
   15.9 Market Attractiveness Analysis By Products and Services
   15.10 Middle East & Africa (MEA) Protein Sequencing Market Size Forecast By Technology
      15.10.1 Sequencing-by-degradation
      15.10.2 Sequencing-by-transit
      15.10.3 Sequencing-by-affinity
   15.11 Basis Point Share (BPS) Analysis By Technology
   15.12 Absolute $ Opportunity Assessment By Technology
   15.13 Market Attractiveness Analysis By Technology
   15.14 Middle East & Africa (MEA) Protein Sequencing Market Size Forecast By Application
      15.14.1 Biomarker Discovery
      15.14.2 Protein Engineering Studies
      15.14.3 Biotherapeutics
      15.14.4 Others
   15.15 Basis Point Share (BPS) Analysis By Application
   15.16 Absolute $ Opportunity Assessment By Application
   15.17 Market Attractiveness Analysis By Application
   15.18 Middle East & Africa (MEA) Protein Sequencing Market Size Forecast By End-User
      15.18.1 Academic Institutes & Research Centers
      15.18.2 Pharmaceutical & Biotechnology Companies
      15.18.3 Contract Research Organizations
      15.18.4 Others
   15.19 Basis Point Share (BPS) Analysis By End-User
   15.20 Absolute $ Opportunity Assessment By End-User
   15.21 Market Attractiveness Analysis By End-User
Chapter 16 Competition Landscape
   16.1 Protein Sequencing Market: Competitive Dashboard
   16.2 Global Protein Sequencing Market: Market Share Analysis, 2022
   16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      16.3.1 Agilent Technologies, Inc.
      16.3.2 AltaBioscience Ltd
      16.3.3 Bioinformatics Solutions
      16.3.4 Bruker
      16.3.5 Charles River Laboratories
      16.3.6 Creative Proteomics
      16.3.7 Proteome Factory
      16.3.8 Quantum-Si, Inc
      16.3.9 Rapid Novor Inc.
      16.3.10 Selvita SA
      16.3.11 SGS SA
      16.3.12 Shimadzu Corporation
      16.3.13 Thermo Fisher Scientific Inc.

Methodology

Our Clients

Siemens Healthcare
FedEx Logistics
Microsoft
General Mills
Dassault Aviation
Deloitte
General Electric
Pfizer